Boston Home, Inc (the) in Boston, MA

Boston Home, Inc (the) is a medicare and medicaid certified nursing home in Boston, Massachusetts. It is located in Suffolk county at 2049 Dorchester Avenue, Boston, Massachusetts 02124. You can reach out to the office of Boston Home, Inc (the) via phone at (617) 825-3905. This skilled nursing facility has 96 federally certified beds with average occupancy rate of 95.21%. Its legal business name is Boston Home Inc and has the following ownership type - Non Profit - Corporation.

Boston Home, Inc (the) (Medicare CCN 225434) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1990 (34 years certified) and the last quality survey was conducted in May, 2019.

Name	Boston Home, Inc (the)
Location	2049 Dorchester Avenue, Boston, Massachusetts
Certified By	Medicare and Medicaid
No. of Certified Beds	96
Occupancy Rate	95.21%
Medicare ID (CCN)	225434
Legal Business Name	Boston Home Inc
Ownership Type	Non Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Boston Home, Inc (the) from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1811990930
Organization Name	BOSTON HOME INC
Doing Business As	THE BOSTON HOME INC
Address	2049 Dorchester Ave, Boston, MA 02124
Phone Number	617-825-3905

News Archive

Duke researchers show how to retrain immune system of peanut-allergy mice

Treating food allergies might be a simple matter of teaching the immune system a new trick, researchers at Duke Health have found.

Specialists offer new technique for nostril reconstruction

The skin cancer growing on Carolyn Bohlmann's nose was not a very aggressive variety. But it was deep and located right on her nostril. The tricky part was not so much removing it - MOHS surgery, the procedure Bohlmann had, is a fairly common outpatient procedure.

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

Qnexa took a step closer to approval on Wednesday, when outside advisers to the U.S. Food and Drug Administration voted 20-to-2 in favor of approval. The panel also recommended the company conduct a study to scrutinize even more closely any risk of heart problems. That study may be required after the drug is approved. Should the FDA ask for further data on heart risks before any approval, it would delay Qnexa's launch further.

Cancer genetics pioneer, Bert Vogelstein, awarded the Breakthrough Prize in Life Sciences

Bert Vogelstein, M.D., co-director of the Ludwig Center at Johns Hopkins and a Howard Hughes Medical Institute investigator has been awarded the Breakthrough Prize in Life Sciences. He was selected for his landmark work in cancer genomics and tumor suppressor genes.

Read more Medical News

› Verified 2 days ago

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Boston Home, Inc (the) are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Boston Home, Inc (the) give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Duke researchers show how to retrain immune system of peanut-allergy mice

Treating food allergies might be a simple matter of teaching the immune system a new trick, researchers at Duke Health have found.

Specialists offer new technique for nostril reconstruction

The skin cancer growing on Carolyn Bohlmann's nose was not a very aggressive variety. But it was deep and located right on her nostril. The tricky part was not so much removing it - MOHS surgery, the procedure Bohlmann had, is a fairly common outpatient procedure.

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

Qnexa took a step closer to approval on Wednesday, when outside advisers to the U.S. Food and Drug Administration voted 20-to-2 in favor of approval. The panel also recommended the company conduct a study to scrutinize even more closely any risk of heart problems. That study may be required after the drug is approved. Should the FDA ask for further data on heart risks before any approval, it would delay Qnexa's launch further.

Cancer genetics pioneer, Bert Vogelstein, awarded the Breakthrough Prize in Life Sciences

Bert Vogelstein, M.D., co-director of the Ludwig Center at Johns Hopkins and a Howard Hughes Medical Institute investigator has been awarded the Breakthrough Prize in Life Sciences. He was selected for his landmark work in cancer genomics and tumor suppressor genes.

Read more Medical News

› Verified 2 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Boston Home, Inc (the) is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	6.59	14.46
Percentage of long-stay residents who lose too much weight	2.65	5.51